Dividend policy

The guiding principle of the Issuer’s Management Board regarding dividends is to pay dividends in accordance with the amount of profit generated and the current capabilities of the Issuer. The Management Board submits proposals concerning dividend payment with consideration of the need to ensure the financial liquidity of the Issuer and secure the capital required for business development. When deciding on the recommendation of dividend payment, the Management Board of the Issuer considers, in particular, the current and future financial situation of the Issuer’s Group, strategic objectives and the effectiveness of the investment projects planned by the Issuer’s Group.

Amount of dividend for every fiscal year from 2013 to 2022:

Item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Consolidated net income (PLN thousand) 6,909

10,019

10,307

14,841

5,364

7,045

-2,031

935,569

444,852

-190,786

Amount of planned divided (PLN thousand)

259

2,161

0

1,377

0

0

5,295

0

0

23,873

Amount of approved and paid-out dividend (PLN thousand)

259

2,161

0

1,377

0

0

5,203 1)

0 2)

0

23,873 3)

Number of shares

8,643,400

8,643,400

8,643,400

10,589,100

10,589,100

10,589,100

10,603,414

10,604,525

10,647,166

10,647,166 4)

Par value of a share (PLN)

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

Dividend value per share (PLN)

0.03

0.25

0.0

0.13

0.00

0.00

0.50

0,00

0.00

2.50

Dividend day

8.07.2014 r.

2.07.2015 r.

-

11.07.2017 r.

-

-

19.06.2020 r.

-

-

30.06.2023 r.

Payment date

25.07.2014 r.

20.07.2015 r.

-

18.07.2017 r.

-

-

26.06.2020 r.

-

-

14.07.2023 r.

 

1) The dividend was not paid on own shares purchased by the Issuer. Moreover, on June 3, 2020, the Ordinary General Meeting adopted a resolution to allocate the amount of PLN 30,700,000.00 to the reserve capital intended for the purchase of own shares.

2) On April 20, 2021, the Ordinary General Meeting of the Issuer adopted a resolution to allocate the amount of PLN 312,025,147.32 to the reserve capital intended for the purchase of own shares.

3) During 2023, the Issuer's subsidiary also allocated the amount of PLN 16,268,501.00 for the purchase of the Issuer's shares.

4) The dividend was paid on a total of 9,549,284 shares of the Issuer. The dividend was not paid on the Issuer's own shares held by the Issuer and the Issuer's subsidiary

To jest wyrób medyczny. Używaj go zgodnie z instrukcją używania lub etykietą.